Related Experiment Video
Updated: Nov 24, 2025

Author Spotlight: Exploring the Mysteries of Sichuan's Herbal Medicine in Chinese Medicine Research
Published on: March 1, 2024
[Chronic gastrite: modern state of the problem]
O N Minushkin1, I V Zverkov1, N V Lvova2
1Central State Medical Academy of Department of Presidential Affairs.
Ursodeoxycholic acid (UDCA) effectively treats chronic biliary reflux gastritis. This study found UDCA drugs to be the treatment of choice for this condition, showing significant efficacy in patients.
Area of Science:
- Gastroenterology
- Hepatology
- Pharmacology
Background:
- Chronic gastritis is a prevalent condition with diverse etiologies.
- Biliary reflux gastritis, a subtype, involves bile acid-induced damage.
- Current classifications may not adequately address this specific form.
Purpose of the Study:
- To review current understanding of chronic gastritis.
- To evaluate the efficacy of ursodeoxycholic acid (UDCA) in treating biliary reflux gastritis.
- To advocate for a distinct classification for biliary reflux gastritis.
Main Methods:
- A review of modern concepts in chronic gastritis.
- Clinical study involving 50 patients with chronic biliary reflux gastritis.
- Treatment with Grinterol (a UDCA drug) at 12.5 mg/kg/day for 4 weeks.
Main Results:
- Ursodeoxycholic acid (UDCA) drugs are identified as primary treatment for biliary reflux gastritis.
- Endomorphological efficacy reached 76%, with 100% clinical efficacy.
- The study supports UDCA's role in managing this condition.
Conclusions:
- A new classification recognizing biliary reflux gastritis is warranted.
- UDCA drugs demonstrate high effectiveness in treating chronic biliary reflux gastritis.
- This supports the scientific justification for classifying biliary reflux gastritis separately.
Related Concept Videos
Gastritis-II: Pathophysiology
In acute gastritis, the gastric mucosa becomes swollen and red and undergoes superficial erosion. Superficial ulceration may lead to bleeding.
In chronic gastritis, persistent or repeated insults lead to chronic inflammatory changes and, eventually, thinning or atrophy of the gastric tissue.
Gastritis can stem from various causes, each...
Gastritis-I: Introduction and Types
Acute gastritis presents as a sudden inflammation triggered by various stressors to the stomach lining, such as exposure to corrosive agents, local irritants like aspirin and other NSAIDs, alcohol consumption, radiation therapy, physical trauma, severe burns, sepsis,...
Gastritis III: Clinical Manifestations and Management
Clinical manifestations of acute gastritis
The patient with acute gastritis may have a rapid onset of symptoms, such as epigastric pain or discomfort, dyspepsia, anorexia, hiccups, or nausea and vomiting, which can last from a few hours to a few days. Erosive or hemorrhagic gastritis may cause bleeding, which may manifest as blood in vomit or as...
Chronic Pancreatitis I: Introduction
Pancreatitis is the inflammation of the pancreas, which occurs when the immune system becomes active and causes swelling, pain, and disruptions in organ function. Pancreatitis can manifest as either an acute or chronic condition.
Acute pancreatitis arises suddenly and lasts for a brief duration, while chronic pancreatitis is a long-term affliction...
Peptic Ulcer Disease I: Introduction
An acute ulcer, marked by superficial erosion and minimal inflammation, swiftly resolves upon identifying and addressing the underlying cause. In contrast, a chronic ulcer persists, potentially eroding through the muscular wall and forming fibrous tissue.
Peptic ulcers can also be...
Other Disorders of Digestive System

